AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
stockNASDAQ
At CloseNov 5, 2026 3:59:59 PM EST
19.46USD-2.456%(-0.49)3,406,852
Pre-marketNov 5, 2026 9:21:30 AM EST
20.00USD+0.251%(+0.05)
After-hoursNov 5, 2026 4:39:30 PM EST
19.45USD-0.051%(-0.01)
AMRX Financials
In Q3 FY 2026 (ended ), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) reported revenue of $862.68M, net income of $12.31M, operating cash flow of $98.3M, and assets of $5.27B (filed ).
Loading financial flows…